Flow cytometric analysis of the cadmium-exposed green alga Chlamydomonas reinhardtii (Chlorophyceae) by Jamers, An, Lenjou, Marc, Deraedt, Pieter, Bockstaele, Dirk Van, Blust, Ronny, Coen, Wim de

Get full text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a ra... by Moreau, Philippe, Attal, Michel, Hulin, Cyrille, Arnulf, Bertrand, Belhadj, Karim, Benboubker, Lotfi, Béné, Marie C, Broijl, Annemiek, Caillon, Hélène, Caillot, Denis, Corre, Jill, Delforge, Michel, Dejoie, Thomas, Doyen, Chantal, Facon, Thierry, Sonntag, Cécile, Fontan, Jean, Garderet, Laurent, Jie, Kon-Siong, Karlin, Lionel, Kuhnowski, Frédérique, Lambert, Jérôme, Leleu, Xavier, Lenain, Pascal, Macro, Margaret, Mathiot, Claire, Orsini-Piocelle, Frédérique, Perrot, Aurore, Stoppa, Anne-Marie, van de Donk, Niels WCJ, Wuilleme, Soraya, Zweegman, Sonja, Kolb, Brigitte, Touzeau, Cyrille, Roussel, Murielle, Tiab, Mourad, Marolleau, Jean-Pierre, Meuleman, Nathalie, Vekemans, Marie-Christiane, Westerman, Matthijs, Klein, Saskia K, Levin, Mark-David, Fermand, Jean Paul, Escoffre-Barbe, Martine, Eveillard, Jean-Richard, Garidi, Reda, Ahmadi, Tahamtan, Zhuang, Sen, Chiu, Christopher, Pei, Lixia, de Boer, Carla, Smith, Elena, Deraedt, William, Kampfenkel, Tobias, Schecter, Jordan, Vermeulen, Jessica, Avet-Loiseau, Hervé, Sonneveld, Pieter

Get full text

DVRd Followed By Ciltacabtagene Autoleucel Versus DVRd Followed By ASCT in Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible: A Randomized Phase 3 Study (E... by Boccadoro, Mario, San-Miguel, Jesús, Suzuki, Kenshi, Van De Donk, Niels W.C.J., Cook, Gordon, Jakubowiak, Andrzej, Madduri, Deepu, Afifi, Salma, Stevens, An-Sofie, Schecter, Jordan M., Deraedt, William, Kuppens, Steven, Mistry, Pankaj, Pacaud, Lida, Florendo, Erika, Broijl, Annemiek, Gay, Francesca, Mina, Roberto, Rasche, Leo, Moreau, Philippe, Mateos, María-Victoria, Einsele, Hermann, Sonneveld, Pieter

Get full text

Impact of Modified Dose Schedule of Bortezomib, Melphalan, and Prednisone (VMP) for Previously Untreated, Transplant-Ineligible Patients with Multiple Myeloma (MM): A Matching-Adju... by San-Miguel, Jesus F, Mateos, Maria-Victoria, Goldschmidt, Hartmut, Sonneveld, Pieter, Dimopoulos, Meletios A, Heeg, Bart, Hashim, Mahmoud, Deraedt, William, Hu, Peter, Lam, Annette, He, Jianming

Get full text

The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted in... by Mateos, Maria-Victoria, San-Miguel, Jesus, Goldschmidt, Hartmut, Sonneveld, Pieter, Dimopoulos, Meletios A., Heeg, Bart, Hashim, Mahmoud, Deraedt, William, Hu, Peter, Lam, Annette, He, Jianming

Get full text

Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy... by Chanan-Khan, Asher A., Lentzsch, Suzanne, Quach, Hang, Horvath, Noemi, Capra, Marcelo, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Qi, Ming, Deraedt, William, Schecter, Jordan, Amin, Himal, Qin, Xiang, Casneuf, Tineke, Chiu, Christopher, Sasser, A. Kate, Sonneveld, Pieter

Get full text

Risk of Second Primary Malignancies (SPMs) Following Bortezomib (Btz)-Based Therapy: Analysis of Four Phase 3 Randomized Controlled Trials in Previously Untreated or Relapsed Multi... by Miguel, Jesús F San, Richardson, Paul G., Orlowski, Robert Z., Goldschmidt, Hartmut, Corzo, Deyanira, Satler, Carol, Esseltine, Dixie-Lee, Neuwirth, Rachel, Ponsillo, Maria, Cakana, Andrew Z, King, Jay, Deraedt, William M, Desai, Avinash, Lutska, Yana, Gifkins, Dina, Liu, Kevin, Sonneveld, Pieter

Get full text